Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.75
Bid: 18.00
Ask: 19.50
Change: 0.25 (1.35%)
Spread: 1.50 (8.333%)
Open: 18.50
High: 19.50
Low: 17.75
Prev. Close: 18.50
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg cuts Anglo American and Gem Diamonds

Thu, 06th Oct 2022 10:46

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

Bank of America raises Admiral Group price target to 2,000 (1,960) pence - 'underperform'

----------

Bank of America cuts Prudential price target to 1,360 (1,455) pence - 'buy'

----------

Bank of America cuts Aviva price target to 480 (500) pence - 'neutral'

----------

Bank of America cuts Hargreaves Lansdown price target to 1,050 (1,100) pence - 'buy'

----------

Bank of America cuts M&G price target to 222 (245) pence - 'buy'

----------

Deutsche Bank cuts M&G price target to 200 (230) pence - 'hold'

----------

Bank of America cuts Phoenix Group price target to 725 (800) pence - 'buy'

----------

HSBC raises Legal & General price target to 350 (335) pence - 'buy'

----------

Bank of America cuts Legal & General price target to 280 (315) pence - 'buy'

----------

Deutsche Bank cuts St James's Place target to 1,370 (1,420) pence - 'buy'

----------

Bank of America cuts St James's Place price target to 1,300 (1,435) pence - 'neutral'

----------

RBC raises Segro to 'outperform' (sector perform) - price target 900 (1,075) pence

----------

RBC cuts British Land price target to 330 (375) pence - 'sector perform'

----------

RBC cuts Land Securities price target to 550 (650) pence - 'sector perform'

----------

Goldman Sachs raises Standard Chartered price target to 890 (870) pence - 'buy'

----------

Goldman Sachs raises HSBC price target to 750 (705) pence - 'neutral'

----------

UBS cuts Intertek price target to 6,000 (6,500) pence - 'buy'

----------

UBS cuts RS Group price target to 1,300 (1,375) pence - 'buy'

----------

UBS cuts Experian price target to 3,200 (3,400) pence - 'buy'

----------

Goldman Sachs cuts Auto Trader Group price target to 621 (625) pence - 'neutral'

----------

HSBC cuts Auto Trader Group price target to 740 (795) pence - 'buy'

----------

Goldman Sachs cuts Tesco price target to 245 (255) pence - 'buy'

----------

Credit Suisse cuts Tesco price target to 238 (292) pence - 'neutral'

----------

Credit Suisse cuts Sainsbury price target to 184 (231) pence - 'underperform'

----------

Goldman Sachs cuts Next price target to 5,750 (7,600) pence - 'neutral'

----------

RBC raises Burberry price target to 1,800 (1,700) pence - 'sector perform'

----------

Goldman Sachs raises Burberry price target to 2,490 (2,410) pence - 'buy'

----------

Exane BNP starts Entain with 'outperform' - price target 13,500 pence

----------

Exane BNP starts Flutter with 'outperform' - price target 12,500 pence

----------

Deutsche Bank cuts Reckitt price target to 6,900 (7,200) pence - 'buy'

----------

Berenberg cuts Anglo American to 'hold' (buy) - price target 3,000 (3,200) pence

----------

Berenberg cuts Endeavour Mining price target to 2,900 (3,000) pence - 'buy'

----------

Berenberg raises Fresnillo price target to 800 (700) pence - 'hold'

----------

Berenberg cuts Rio Tinto price target to 4,000 (4,300) pence - 'sell

----------

FTSE 250

----------

Berenberg cuts Sirius Real Estate price target to 123 (150) pence - 'buy'

----------

RBC cuts Great Portland price target to 470 (485) pence - 'underperform'

----------

RBC cuts Workspace Group price target to 600 (675) pence - 'outperform'

----------

RBC cuts Derwent London price target to 2,000 (2,100) pence - 'underperform'

----------

RBC cuts Hammerson price target to 15.5 (16.5) pence - 'underperform'

----------

RBC cuts Big Yellow Group price target to 1,100 (1,200) pence - 'underperform'

----------

RBC cuts Warehouse REIT price target to 115 (120) pence - 'underperform'

----------

RBC cuts Tritax Eurobox price target to 90 (105) pence - 'outperform'

----------

RBC cuts Tritax Big Box price target to 190 (205) pence - 'outperform'

----------

RBC cuts LondonMetric Property price target to 245 (270) pence - 'outperform'

----------

Barclays cuts Computacenter price target to 2,385 (2,900) pence - 'equal weight'

----------

Barclays cuts Babcock International target to 325 (358) pence - 'equal weight'

----------

Jefferies cuts Spire Healthcare price target to 240 (251) pence - 'hold'

----------

Jefferies cuts Johnson Matthey price target to 2,300 (2,400) pence - 'buy'

----------

Numis cuts Synthomer to 'hold' ('add') - target 120 (230) pence

----------

Berenberg raises Centamin price target to 114 (112) pence - 'buy'

----------

UBS cuts Serco price target to 190 (210) pence - 'buy'

----------

Barclays cuts Renishaw price target to 3,520 (3,975) pence - 'underweight'

----------

Berenberg cuts John Wood price target to 180 (270) pence - 'buy'

----------

UBS cuts Hays price target to 160 (220) pence - 'buy'

----------

Bank of America cuts Quilter price target to 104 (115) pence - 'underperform'

----------

Bank of America cuts Direct Line price target to 185 (195) pence - 'underperform'

----------

JPMorgan cuts Close Brothers price target to 1,240 (1,370) pence - 'neutral'

----------

Bank of America cuts Ninety One price target to 215 (220) pence - 'neutral'

----------

Bank of America raises Man Group price target to 305 (300) pence - 'buy'

----------

Bank of America cuts Jupiter Fund price target to 85 (115) pence - 'underperform'

----------

Bank of America cuts Ashmore Group price target to 175 (185) pence - 'underperform'

----------

Deutsche Bank cuts abrdn price target to 125 (135) pence - 'sell'

----------

Credit Suisse cuts Moneysupermarket target to 202 (208) pence - 'neutral'

----------

SMALL CAP

----------

UBS cuts Just Eat Takeaway price target to 2,200 (2,400) pence - 'buy'

----------

Berenberg raises Yellow Cake price target to 600 (500) pence - 'buy'

----------

Berenberg raises Yamana Gold price target to 660 (640) pence - 'buy'

----------

Berenberg cuts Resolute Mining price target to 48 (49) pence - 'buy'

----------

Berenberg cuts Tharisa price target to 250 (270) pence - 'buy'

----------

Berenberg raises Sovereign Metals price target to 84 (75) pence - 'buy'

----------

Berenberg cuts Jubilee Metals price target to 19 (20) pence - 'buy'

----------

Berenberg cuts Hochschild Mining price target to 90 (100) pence - 'hold'

----------

Berenberg cuts Griffin Mining price target to 140 (160) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 280 (300) pence - 'buy'

----------

Berenberg raises BHP Group price target to 2,300 (2,100) pence - 'hold'

----------

Berenberg cuts Atalaya Mining price target to 310 (370) pence - 'buy'

----------

Berenberg cuts Anglo Pacific Group price target to 330 (390) pence - 'buy'

----------

Berenberg raises Petra Diamonds to 'buy' (hold) - price target 200 (130) pence

----------

Berenberg cuts Gem Diamonds to 'hold' (buy) - price target 40 (60) pence

----------

RBC raises Empiric Student Property target to 90 (84) pence - 'sector perform'

----------

Jefferies cuts Angle price target to 170 (200) pence - 'buy'

----------

Bank of America cuts Old Mutual price target to 68.50 (76) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 Feb 2019 11:35

Angle's 'Parsortix' used in new groundbreaking cancer research

(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 'Parsortix' system had been utilised in further "groundbreaking" cancer research into CTC clusters, reportedly demonstrating that the patient's own immune cells (neutrophils) could actively help the process of metastasis by which the cancer spread.

Read more
31 Jan 2019 12:04

Angle Reports Widened Interim Loss On Higher Operating Costs

LONDON (Alliance News) - Angle PLC on Thursday reported a widened interim loss on an increase operating costs.In the six months to October 31, the tumour cell researcher said its pretax to

Read more
24 Jan 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 25 January BonmarcheTrading Statement AG BarrTrading GroupQ3 Smaller

Read more
10 Jan 2019 17:05

Angle Shares Jump As Parsortix System Used In New Cancer Treatment

LONDON (Alliance News) - Angle PLC shares spiked late Thursday afternoon after the company said its Partsortix system will be used in "ground-breaking" new cancer research.Shares

Read more
5 Nov 2018 12:11

ANGLE To Acquire Remaining Stake In US Subsidiary For GBP467,500 (ALLISS)

LONDON (Alliance News) - Liquid biopsy company ANGLE PLC said on Monday it has agreed to acquire the remaining shares in US subsidiary ANGLE North America Inc it does not own from Parsotix Georgi

Read more
1 Nov 2018 14:09

Angle Appoints Cancer Diagnostic Firm Chief As Non-Executive Director

LONDON (Alliance News) - Biopsy company Angle PLC said Thursday it has appointed the President of Euronext-listed cancer diagnostics firm MDxHealth to its board.Jan Groen joins the board of

Read more
29 Oct 2018 11:27

Angle Pilot Study Shows Promise Of Parsortix In Prenatal Testing

LONDON (Alliance News) - Liquid biopsy company Angle PLC on Monday said it has received positive results from a study examining the use of its Parsortix system in prenatal testing.Shares in

Read more
29 Oct 2018 11:08

Angle sees 'highly encouraging' results from prenatal testing

(Sharecast News) - Medical diagnostics outfit Angle is talking to "several interested parties" to commercialise its testing device after a "highly encouraging" trial indicated it could be adapted as a non-invasive prenatal test.

Read more
25 Oct 2018 12:55

Angle Nearing Completion Of Patient Enrolment Breast Cancer Study

LONDON (Alliance News) - Liquid biopsy firm Angle PLC said it is making good progress on recruiting patients for its ANG-002 clinical study.The study is focusing on a treatment for breast a

Read more
25 Oct 2018 08:52

Angle makes 'good progress' with ANG-002 patient enrolment

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that patient enrolment for its ANG-002 FDA clinical study for metastatic breast cancer had continued to make good progress.

Read more
23 Oct 2018 15:59

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30

Read more
28 Aug 2018 14:17

Angle's Parsortix System Able To Identify Tumour Cells In Glioblastoma

LONDON (Alliance News) - Angle PLC on Tuesday said researchers at the Cancer Metastasis Laboratory, located at the University of Basel, have provided evidence of circulating tumour cell clusters a

Read more
14 May 2018 12:17

ANGLE Appoints Urological Surgeon Greg Shaw As Scientific Advisor

LONDON (Alliance News) - ANGLE PLC said Monday it appointed urological surgeon, Greg Shaw, as a scientific advisor.The liquid biopsy company appointed the prostate cancer UK National Health

Read more
19 Apr 2018 15:02

ANGLE Gets Positive Results From Parsortix System Trials

LONDON (Alliance News) - ANGLE PLC on Thursday said its Parsortix system has developed an optimised workflow for the recovery and culturing of circulating tumour cells.Parsortix allows this

Read more
4 Apr 2018 04:10

Australia shares ease for 4th day as financials drag; NZ higher

* ANZ falls for the eighth straight day * Fonterra slightly lower after NZ milk production falls in Feb By Susan Mathew April 4 (Reuters) - Australian shares eased for a day a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.